期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗乙型肝炎病毒药物的研究进展 被引量：7

Research progress of anti-hepatitis B virus agents
下载PDF
导出
摘要 慢性乙型肝炎病毒感染是一个全球性的健康问题,开发抗乙型肝炎病毒药物一直是个热点。本文通过检索相关医药文献,对近几年来此类药物作一比较和评价,尤其对核苷类药物的研究进展进行着重介绍。 Chronic hepatitis B virus （HBV） infection has become a globally healthy problem. The anti- hepatitis B agents have been hot topics worldwide. The comparison and evaluation of recent anti-HBV agents are made by searching related literature, and especially the progress of research on nucleoside analogues as novel anti-hepatitis B virus agents is reviewed.
作者 顾婧菡 卓超 闫丽
机构地区 华东理工大学药学院
出处 《国外医学（药学分册）》 2007年第2期110-114,共5页 Foreign Medical Sciences(Section of Pharmarcy)
关键词 核苷类药物 乙型肝炎病毒 nucleoside analogues hepatitis B virus
分类号 R978.7 [医药卫生—药品]
  • 相关文献

参考文献19

  • 1齐青松,陈仕彬,杨茜,易冬英.拉米夫定治疗慢性乙肝的疗效及乙肝病毒YMDD变异的研究[J].江西医学院学报,2005,45(5):42-45. 被引量：8
  • 2舒欣,李刚,姚集鲁.拉米夫定治疗乙型肝炎耐药性的产生及YMDD变异的研究[J].国外医学（内科学分册）,2000,27(7):302-304. 被引量：13
  • 3Hadziyannis SJ,Tassopoulos NC,Heatheote E J,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B[J].N Engl J Med,2003,348(9):800 -807.
  • 4Angus P,Vaughan R,Xiong S,et al.Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase[J].Gastroenterology,2003,125 (2):292-297.
  • 5Hadziyannis S,Tassopouloe N,Chang TT,et al.Three year study of adefovir dipivoxil(ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study(LTSES)[J].J Hepatol,2004,40(Suppl 1):17.
  • 6Buti M,Esteban R.Entecavir,FTC,L-FMAU,LdT and others[J].J Hepatol,2003,39 (Suppl 1):S139-S142.
  • 7李霖,李玉珍.抗乙肝病毒新药——恩替卡韦[J].临床药物治疗杂志,2006,4(4):56-58. 被引量：30
  • 8Colonno R,Rose R,Levine S,et al.Entecavir (ETV) resistance is not observed in nucleoside-naive subjects and is observed infrequently by week 48 in lamivudine-refractory subjects with chronic HBV infection[J].J hepatol,2005,42 (Suppl 2):173.
  • 9Dando TM,Wagstaff AJ.Emtricitabine/tenofovir disoproxil fumarate[J].Drugs,2004,64(18):2075-2082.
  • 10Gish RG,Trinh H,Leung N,et al.Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection:a two-year study[J].J Hepatol,2005,43 (1):60 -66.

二级参考文献22

  • 1Jia-Zhang Xu Zhi-Guo Yang Mei-Zhao Le Mao-Rong Wang Chang-Lun He Yun-Hua Sui Institute of Hepatology,the 81st Hospital of PLA,Nanjing 210002,Jiangsu Province,ChinaDepartment of Pathology,the 81st Hospital of PLA,Nanjing 210002,Jiangsu Province,China.A study on pathogenicity of hepatitis G virus[J].World Journal of Gastroenterology,2001,7(4):547-550. 被引量：8
  • 2刘传苗,张欣欣,陆志檬.拉米夫定治疗中乙型肝炎病毒YMDD野毒株和变异株的变化[J].肝脏,2004,9(2):73-76. 被引量：19
  • 3林文,张俊平,胡振林,钱定华.苦参碱对细菌脂多糖诱导大鼠枯否细胞释放肿瘤坏死因子及白细胞介素-6的影响[J].药学学报,1997,32(2):93-96. 被引量：68
  • 4蔡雄,王国俊,瞿瑶,樊成辉,张瑞祺,徐文胜.苦参素注射液治疗慢性乙型肝炎临床疗效分析[J].第二军医大学学报,1997,18(1):47-49. 被引量：345
  • 5Knodell RG,Ishak KG,Black WC,et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chromic active hepatitis[J].Hepatology,1981,1:431～435.
  • 6Suzuki Y,Kumada H,Ikeda K,et al.Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection[J].J Hepatol,1999,30:743～748.
  • 7Manns MP,McHutchison JG,Gordon SC,et al.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomized trial[J].Lancet,2001,358:958～965.
  • 8Fired MW.Side effects of therapy for hepatitis C and their management[J].Hepatology,2002,36:237～244.
  • 9Zenzem S,Feinman SV,Resenack J,et al.Peginterferon Alfa-2a in Patients with Chronic Hepatitis B[J].N Engl J Med,2000,343:1 666～1 672.
  • 10骆抗先.乙型肝炎基础与临床[M](第2版)[M].北京:人民卫生出版社,2001.265-279.

共引文献97

同被引文献30

引证文献7

二级引证文献30

国外医学（药学分册）
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部